Latest Share Chat

REMOVE ADS

Astrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes

Get Live Data

14,318.00 256.00 (1.82%)

Bid:

14,256.00

Ask:

14,262.00

Spread: 6.00 (0.042%)

Market Cap: £222.05b

Last checked at -

Intraday Astrazeneca Share Chart

REMOVE ADS

Astrazeneca News

LONDON BROKER RATINGS: Goldman raises IAG; Peel Hunt raises XP Power

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Astrazeneca's Tezspire secures EU approval

(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that its chronic rhinosinusitis with nasal polyps treatment, Tezspire, has been approved in...

AstraZeneca hails US FDA approval for Tezspire for rhinosinusitis form

(Alliance News) - AstraZeneca PLC on Monday said its lupus drug Saphnelo received a positive opinion from the European Medicines Agency's committee fo...

LONDON BRIEFING: B&M cuts profit view; Astra drug gets FDA backing

(Alliance News) - B&M European Value Retail cuts its profit guidance following an accounting error and says Chief Financial Officer Mike Schmidt will ...

AstraZeneca lupus treatment gets EU approval

(Sharecast News) - AstraZeneca has received the green light from European regulators for its Saphnelo treatment for lupus, the pharma giant announced ...

Daiichi, AstraZeneca report breast cancer gains with Enhertu, Datroway

(Alliance News) - Daiichi Sankyo Co Ltd on Sunday reported promising clinical activity across multiple oncology programmes, including early signals in...

Amgen and AstraZeneca says US FDA broadens indication for Tezspire

(Alliance News) - Amgen Inc and AstraZeneca on Friday said the US Food & Drug Administration had broadened the indication for Tezspire to a second dis...

AstraZeneca's Saphnelo gets nod in EU for systemic lupus erythematosus

(Alliance News) - AstraZeneca PLC on Friday said Saphnelo subcutaneous self-administration has been recommended for approval in the European Union for...